Jaguar Uranium Corp. filed a Form 8-K on October 30, 2026, reporting that its Board of Directors granted stock options to three named executive officers on October 29, 2026, under the company's 2025 Equity Incentive Plan.

Key Highlights

  • CEO grant: Steven Gold, President and Chief Executive Officer, received options to purchase 400,000 Class A common shares.
  • Executive Chairman grant: Luis Ducassi, Executive Chairman, received options to purchase 125,000 Class A common shares.
  • CFO grant: William Avery, Chief Financial Officer, received options to purchase 200,000 Class A common shares.
  • Exercise price: Each option is exercisable at $1.00 per share.
  • Vesting schedule: One-third vested on the October 29, 2026 grant date, one-third vests on April 29, 2027, and one-third vests on October 29, 2027, subject to continued service.
  • Expiration dates: The three tranches expire on October 29, 2031, April 29, 2032, and October 29, 2032, respectively, each exercisable for five years from its vesting date.

Stock Option Awards at Jaguar Uranium: Details of the October 29, 2026 Grants

According to the filing, Jaguar Uranium Corp. (NYSE American:JAGU) disclosed that its Board of Directors approved stock option grants on October 29, 2026, under the Jaguar Uranium Corp. 2025 Equity Incentive Plan, as amended. The options cover Class A common shares, no par value, of the company. In total, options to purchase 725,000 Common Shares were granted across the three officers named in the filing.

The filing states that each option is exercisable for one Common Share at an exercise price of $1.00 per share. The vesting structure is identical for all three recipients: one-third vested immediately on the grant date of October 29, 2026, one-third will vest on April 29, 2027, and the remaining one-third will vest on October 29, 2027. The filing specifies that vesting is "subject to the recipient's continued service with the Company through each applicable vesting date."

Each vested tranche carries a five-year exercise window from its respective vesting date. As disclosed, this means the first tranche expires October 29, 2031, the second tranche expires April 29, 2032, and the third tranche expires October 29, 2032. The grants were made under Item 5.02 of Form 8-K, which covers compensatory arrangements of certain officers. The company is incorporated in British Columbia, Canada, and identified as an emerging growth company in the filing.

What Was Disclosed

Jaguar Uranium Corp. reported the grant of stock options to its CEO, Executive Chairman, and CFO on October 29, 2026, covering a combined 725,000 Class A common shares at $1.00 per share, with a three-tranche vesting schedule and expiration dates ranging from 2031 to 2032.